Innovent Biologics Inc. (IVBXF)
OTC: IVBXF
· Real-Time Price · USD
9.62
-0.88 (-8.38%)
At close: Jun 17, 2025, 10:41 AM
Innovent Biologics Revenue
Innovent Biologics reported an annual revenue of $9.42B, reflecting a 51.82% growth. For the quarter ending December 31, 2024, Innovent Biologics generated $5.47B in revenue.
Revenue (ttm)
$9.42B
Revenue Growth
51.82%
Price / Sales Ratio
5.5
Revenue / Employee
$1.66M
Employees
5,659
Market Cap
15.88B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|